C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1998
11/10/1998	US5834254 Stabilized enzyme compositions for nucleic acid amplification
11/10/1998	US5834253 Dna polymerase functions to remove mismatched nucleotides from the 3' terminus of the dna strand at a rate faster than the rate at which the dna polymerase functions to remove nucleotides matched correctly with nucleotides of the template
11/10/1998	US5834252 End-complementary polymerase reaction
11/10/1998	US5834250 Replacement of segment of polypeptide; calibration
11/10/1998	US5834248 Treatment and diagnosis of cardiovascular disease
11/10/1998	US5834247 Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein
11/10/1998	US5834246 Recombinant systems for expression of cholera B-subunit with the aid of foreign promoters and/or leader peptides
11/10/1998	US5834245 Platelet-derived growth factor receptor beta-like tumor suppressor (prlts), from the short arm of human chromosome 8; distinguishing tumor cells from normal cells; host cells transformed with expression vectors for its production
11/10/1998	US5834244 Factor VIIa inhibitors from Kunitz domain proteins
11/10/1998	US5834243 Deformylating recombinant protein in a bacterial host cell
11/10/1998	US5834242 Human clathrin-associated protein
11/10/1998	US5834241 Vesicle trafficking protein
11/10/1998	US5834240 Therapy, prevention, diagnosis
11/10/1998	US5834239 Polynucleotide sequence, a complementary sequence, expression vector and a culturable host cell; medical diagnosis; anticarcinogenic agents
11/10/1998	US5834238 Human GTP binding protein
11/10/1998	US5834237 First cassette containing dna fragment coding for protein under control of thiamine-regulable promoter region, second cassette containing fragment coding for activator of thiamine-regulable genes
11/10/1998	US5834236 AATT repeat transcription enhancer element
11/10/1998	US5834234 Nucleotide sequence coding; diagnosis of degenerative disorders
11/10/1998	US5834233 Cells transformed with a regulatably expressible gene whose expression results in the formation of a cytoplasmically active hydrolytic enzyme; expressing a pesticide or pollutant degrading proteins with said gene
11/10/1998	US5834221 Contacting body fluid sample with immunological binding partner specific for 3-hydroxypyridinium crosslinked peptide derived from carboxy-terminal telopeptide domain of type i collagen
11/10/1998	US5834214 Quantitative analysis of blood sample using immunoassay
11/10/1998	US5834213 Screening system and assay for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
11/10/1998	US5834212 Anti-human stromelysin monoclonal antibody and method for diagnosis of rheumatoid arthritis by enzyme immunoassay
11/10/1998	US5834210 Stable troponin subunits and complexes
11/10/1998	US5834209 Bcl-x/bcl-2 associated cell death regulator
11/10/1998	US5834208 Tyrosine kinase
11/10/1998	US5834202 Methods for the isothermal amplification of nucleic acid molecules
11/10/1998	US5834201 Nucleic acid marker ladder for estimating mass
11/10/1998	US5834199 Methods of identifying transition metal complexes that selectively cleave regulatory elements of mRNA and uses thereof
11/10/1998	US5834198 Selective photoinducted flavin-dependent cleavage of RNA at G-U base pairs and kits therefor
11/10/1998	US5834193 Contacting denatured chromosomal dna with labeled probe having sequence complementary to a telomere repeat sequence under conditions such that said probe hybridizes specifically to telomeric dna, measuring bound probe, correlating with length
11/10/1998	US5834192 Amino acid sequences, nucleotide sequenes and complements; identified from breast tumor libraries; diagnosing with hybridization complexes; host cells transfected with expression vectors; antisense molecules for treatment
11/10/1998	US5834191 Gene expression in filamentous fungi, neurospora crassa, modification of glucoamylase gene
11/10/1998	US5834190 Amplifying microsatellite structures
11/10/1998	US5834189 Treating sample with mixture of polymerase, nucleotides, chain terminating nucleotide(s) and sequencing primer, then measuring lengths of oligonucleotide fragments; for genetic testing, human leukocyte antigen genes
11/10/1998	US5834188 For inducing human osteogenic protein 1
11/10/1998	US5834186 Regulatable RNA molecule
11/10/1998	US5834185 Detection, altering gene expression of target sequence
11/10/1998	US5834184 In vivo selection of RNA-binding peptides
11/10/1998	US5834183 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis
11/10/1998	US5834182 Treating cells with agents that alter dna metabolism
11/10/1998	US5833995 Innoculating with a polypeptide comprising an anigenic portion of the virus stuctural protein
11/10/1998	US5833993 Feline immunodeficiency virus vaccine
11/10/1998	US5833991 A glycine-rich amino acid sequence is inserted into a fusion protein to prevent an immunogenic response; gene therapy; transfer vectors; vaccines
11/10/1998	US5833989 Complement receptor type 1 protein was encoded by plasmides having no more three inserted short consensus repeats nucleotide; use in inflammatory, brain, nevous system and immune disorders
11/10/1998	US5833986 Methods of inhibiting the growth of neoplasia using a monoclonal antibody against α platelet derived growth factor receptor
11/10/1998	US5833981 Human phosphorylase kinase gamma subunit
11/10/1998	US5833979 Methods and compositions of growth control for cells encapsulated within bioartificial organs
11/10/1998	US5833975 Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
11/10/1998	US5833943 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
11/10/1998	US5833651 Lumen wall contacting surface coated with fibrin; virus loading solution applied to the stent; gene transfer to a cell
11/10/1998	CA2045649C Attenuated enteroviruses and rhinoviruses
11/10/1998	CA2002480C Process for the production of human lysozyme
11/10/1998	CA1340122C Modifications of somatotropins for enhanced stability
11/09/1998	WO1998039438A1 Antisense compounds to cd14
11/09/1998	CA2253877A1 Antisense compounds to cd14
11/07/1998	CA2231754A1 A novel human g-protein coupled receptor hcept09
11/07/1998	CA2230986A1 Epo primary response gene 1, eprg1
11/06/1998	CA2204572A1 Transgenic mice expressing hiv-1 in immune cells and uses thereof as an animal model of aids
11/05/1998	WO1998049560A1 Cadherin-11 as an indicator of viable pregnancy
11/05/1998	WO1998049350A1 In vivo use of recombinagenic oligonucleobases to correct genetic lesions in hepatocytes
11/05/1998	WO1998049349A1 ANTISENSE INHIBITION OF ras GENE WITH CHIMERIC AND ALTERNATING OLIGONUCLEOTIDES
11/05/1998	WO1998049348A1 Oligonucleotides for enhanced bioavailability
11/05/1998	WO1998049346A1 Enzymatic dna molecules
11/05/1998	WO1998049343A1 Methods of identifying transition metal complexes that selectively cleave regulatory elements of mrna and uses thereof
11/05/1998	WO1998049342A1 Method of preparing a standard diagnostic gene transcript pattern
11/05/1998	WO1998049338A1 Bacterial interaction screening system
11/05/1998	WO1998049337A1 Bioluminescent reporter bacterium and methods for toxicity monitoring in biological wastewater treatment systems
11/05/1998	WO1998049336A1 Metastasis models using green fluorescent protein (gfp) as a marker
11/05/1998	WO1998049335A1 Construct and expression of a retrovirus chimerical envelope by vectors, and pharmaceutical compositions containing same
11/05/1998	WO1998049334A1 Novel internal ribosome entry site and vector containing same
11/05/1998	WO1998049333A2 Eukaryotic gene expression cassette and uses thereof
11/05/1998	WO1998049332A1 Agrobacterium mediated transformation of sorghum
11/05/1998	WO1998049331A1 Antifungal composition containing beta-(1,6)-glucanase, and hosts incorporating same
11/05/1998	WO1998049330A1 Dna sequences coding for subunit chld of plant magnesium chelatases for determining their action
11/05/1998	WO1998049329A1 Expression of fungicide-binding polypeptides in plants for producing fungicide tolerance
11/05/1998	WO1998049328A1 Improved prokaryotic expression of protein
11/05/1998	WO1998049326A1 Method for cleavage of fusion proteins
11/05/1998	WO1998049324A2 Carbohydrate-deficient glycoprotein syndrome type i
11/05/1998	WO1998049323A1 Forms of prostate specific antigen and methods for their detection
11/05/1998	WO1998049322A1 Neurotrypsin
11/05/1998	WO1998049321A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
11/05/1998	WO1998049320A1 SECRETED α-AMYLASE AS A REPORTER GENE
11/05/1998	WO1998049319A1 Human lysophospholipase
11/05/1998	WO1998049318A1 Dna based anti-helicobacter vaccine composition
11/05/1998	WO1998049317A2 Diagnosis and treatment of phosphatase- 0r kinase-related disorders
11/05/1998	WO1998049316A1 Resistance marker for monocotyledons
11/05/1998	WO1998049315A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
11/05/1998	WO1998049314A2 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI)
11/05/1998	WO1998049313A2 Characterization of granulocytic ehrlichia and methods of use
11/05/1998	WO1998049312A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia
11/05/1998	WO1998049311A2 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
11/05/1998	WO1998049310A1 Mammalian cytokine-like factor 7
11/05/1998	WO1998049309A1 Rat st38.2 chemokine
11/05/1998	WO1998049308A1 Ngf variants
11/05/1998	WO1998049307A1 Mammalian cytokine-like receptor
11/05/1998	WO1998049306A1 Human c-type lectin
11/05/1998	WO1998049305A1 Chimeric opg polypeptides
11/05/1998	WO1998049304A1 Neuronal extracellular matrix protein
11/05/1998	WO1998049303A2 Compositions and methods for conferring tick immunity and preventing tick borne diseases

1 ... 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 ... 4023